CD4 and tuberculosis: Forty of 45 patients (89%) being treated for active TB at baseline, and 288 of 321 patients (90%) who were not being treated for active TB and who had a baseline CD4 count <200 cells/mm3 were on trimethoprim-sulfamethoxazole at the time of ART initiation.